Non-small Cell Lung Cancer (NSCLC) Necitumumab in advanced squamous NSCLC approved with EGFR-Expression

Sankawa Yuri

首页> 外文期刊>Oncology research and treatment. >Non-small Cell Lung Cancer (NSCLC) Necitumumab in advanced squamous NSCLC approved with EGFR-Expression

【24h】

Non-small Cell Lung Cancer (NSCLC) Necitumumab in advanced squamous NSCLC approved with EGFR-Expression

机译：EGFR表达批准的晚期鳞状非小细胞肺癌非小细胞肺癌（NSCLC）尼珠单抗

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Oncology research and treatment.》 |2016年第6期|共2页
作者
Sankawa Yuri;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Non-small Cell Lung Cancer (NSCLC) Necitumumab in advanced squamous NSCLC approved with EGFR-Expression [J] . Sankawa Yuri Oncology research and treatment. . 2016,第6期

机译：EGFR表达批准的晚期鳞状非小细胞肺癌非小细胞肺癌（NSCLC）尼珠单抗
2. P3.02b-062 Safety of Necitumumab and Abemaciclib Combination Therapy in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) [J] . Benjamin Besse, Johan Vansteenkiste, Patrick-Aldo Renault, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第1期

机译：Necitumumab和Abemaciclib组合治疗的P3.02B-062患者晚期非小细胞肺癌（NSCLC）的安全性
3. P3.02b-062 Safety of Necitumumab and Abemaciclib Combination Therapy in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) [J] . Benjamin Besse, Johan Vansteenkiste, Patrick-Aldo Renault, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第1期

机译：Necitumumab和Abemaciclib组合治疗的P3.02B-062患者晚期非小细胞肺癌（NSCLC）的安全性
4. Enumeration and ALK Investigation of Circulating Tumor Cells in Non-Small Cell Lung Cancer (NSCLC) Patients Using an Effective In Vivo Technology, the GILUPI CellCollector? [C] . Klaus Luecke, Lukasz Gasiorowski, Stefanie Herold, International Molecular Medicine Tri-Conference. . 2015

机译：使用有效的体内技术（Gilupi Cellcollector
5. 4HPR-X radiation mechanisms of interactions in non-small cell lung cancer (NSCLC) cells in vitro. [D] . Nasca, Melita Maria. 2002

机译：4HPR-X辐射在非小细胞肺癌（NSCLC）细胞中相互作用的体外机制。
6. Current Smoking has a Detrimental Effect on Survival for Epidermal Growth Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK) negative Advanced non-squamous Non-small Cell Lung Cancer (NSCLC) Patients Treated with Pemetrexed Continuation Maintenance [O] . Liping Lin, Juanjuan Zhao, Jiazhu Hu, 2018

机译：当前吸烟对培美曲塞持续维持治疗的表皮生长因子受体（EGFR）和间变性淋巴瘤激酶（ALK）阴性的晚期非鳞状非小细胞肺癌（NSCLC）患者的生存有不利影响
7. 1320_PR: Subgroup analyses of patients with epidermal growth factor receptor (EGFR)-expressing tumors in SQUIRE: A randomized, multicenter, open-label, phase III study of gemcitabine–cisplatin (GC) plus necitumumab (N) versus GC alone in the first-line treatment of patients (pts) with stage IV squamous non-small cell lung cancer (sq-NSCLC) [O] . L. Paz-Ares, M.A. Socinski, J. Shahidi, 2016

机译：1320_pr：表皮生长因子受体（EGFR）患者的亚群分析 - 表达肿瘤患者：一种随机，多中心，开放标签，吉西拜齐铂（GC）加上Necitumumab（N）对GC的第一个研究阶段鳞状非小细胞肺癌（SQ-NSCLC）的患者（PTS）治疗患者（PTS）治疗

Non-small Cell Lung Cancer (NSCLC) Necitumumab in advanced squamous NSCLC approved with EGFR-Expression

著录项

相似文献

相关主题

期刊订阅